Azathioprine is HOSPITAL ONLY for SEVERE ATOPIC DERMATITIS and RENAL TRANSPLANTATION

If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. Click here for the Shared Care Guideline Repository

If sufficient information has not been provided and if you do not feel happy to continue to prescribe, it is advisable to refer the patient back to the specialist clinic and complete and send as soon as possible an 'inappropriate prescribing request communication form' .  

If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. Click here for the Shared Care Guideline Repository

If sufficient information has not been provided and if you do not feel happy to continue to prescribe, it is advisable to refer the patient back to the specialist clinic and complete and send as soon as possible an 'inappropriate prescribing request communication form' .  

Ciclosporin (Neoral) is HOSPITAL ONLY for renal transplant patients and severe resistant childhood psoriasis and atopic eczema

If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records.

Click here for the Shared Care Guideline Repository


If sufficient information has not been provided and if you do not feel happy to continue to prescribe, it is advisable to refer the patient back to the specialist clinic and complete and send as soon as possible an 'inappropriate prescribing request communication form' .
 

Methotrexate is HOSPITAL ONLY for arthritis in children.

Injection formulations are HOSPITAL ONLY.

If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. Click here for the Shared Care Guideline Repository

If sufficient information has not been provided and if you do not feel happy to continue to prescribe, it is advisable to refer the patient back to the specialist clinic and complete and send as soon as possible an 'inappropriate prescribing request communication form' .  

If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. Click here for the Shared Care Guideline Repository

If sufficient information has not been provided and if you do not feel happy to continue to prescribe, it is advisable to refer the patient back to the specialist clinic and complete and send as soon as possible an 'inappropriate prescribing request communication form' .  

If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. Click here for the Shared Care Guideline Repository

If sufficient information has not been provided and if you do not feel happy to continue to prescribe, it is advisable to refer the patient back to the specialist clinic and complete and send as soon as possible an 'inappropriate prescribing request communication form' .  

Adults. only if conventional treatment cannot be tolerated or is not working well enough and infliximab is not suitable, or biological treatment cannot be tolerated or is not working well enough

Last line targeted therapy for patients who experienced treatment failure and/or when other targeted therapies currently approved by NICE are not suitable

Active ankylosing spondylitis that is not controlled well enough with conventional therapy in adults, only if tumour necrosis factor (TNF)-alpha inhibitors are not suitable or do not control the condition well enough.

All medicinal formulations are formulary EXCEPT plasters which are not licensed.

As per the national recommendations from the 2017 consultation on Medicines of Limited Value, Lidocaine Medicated Plasters are HOSPITAL ONLY.

EXCEPT for post herpetic neuralgia (PHN) only for which they are AMBER

NHS England Guidance for CCGs on prescribing OTC products (Mar-18):

• Prescription for infrequent constipation treatment should not be routinely offered
• Self limiting condition. It can be effectivelu managed with a change in diet or lifestyle.
• Exception: ‘Red Flag’ symptoms

NHS England Guidance for CCGs on prescribing OTC products (Mar-18):

• Prescription for infrequent constipation treatment should not be routinely offered
• Self limiting condition. It can be effectivelu managed with a change in diet or lifestyle.
• Exception: ‘Red Flag’ symptoms

NHS England Guidance for CCGs on prescribing OTC products (Mar-18):

• Prescription for infrequent constipation treatment should not be routinely offered
• Self limiting condition. It can be effectivelu managed with a change in diet or lifestyle.
• Exception: ‘Red Flag’ symptoms

NHS England Guidance for CCGs on prescribing OTC products (Mar-18):

• Prescription for infrequent constipation treatment should not be routinely offered
• Self limiting condition. It can be effectivelu managed with a change in diet or lifestyle.
• Exception: ‘Red Flag’ symptoms

NHS England Guidance for CCGs on prescribing OTC products (Mar-18):

• Prescription for infrequent constipation treatment should not be routinely offered
• Self limiting condition. It can be effectivelu managed with a change in diet or lifestyle.
• Exception: ‘Red Flag’ symptoms

NHS England Guidance for CCGs on prescribing OTC products (Mar-18):

• Prescription for infrequent constipation treatment should not be routinely offered
• Self limiting condition. It can be effectivelu managed with a change in diet or lifestyle.
• Exception: ‘Red Flag’ symptoms

According to the NELMMN (North East London Medicines Management Network) this medication is UNSUITABLE for prescribing in Primary Care.

• NELMMN list

For palliative care initiation only.

NHS England Guidance for CCGs on prescribing OTC products (Mar-18):

• Prescription for infrequent constipation treatment should not be routinely offered
• Self limiting condition. It can be effectivelu managed with a change in diet or lifestyle.
• Exception: ‘Red Flag’ symptoms

LIRAGLUTIDE (SAXENDA) FOR MANAGEMENT OF OVERWEIGHT AND OBESITY ALONGSIDE A REDUED-CALORIE DIET AND INCREASED PHYSICAL ACTIVITY IN ADULTS - HOSPITAL ONLY

Further informatiin - NICE TA 664 - Click here

NHS England guidance for CCGs on prescribing of OTC products (Mar-18):

• ADULTS ONLY - THIS RECOMMENDATION DOES NOT APPLY TO CHILDREN
• Prescription for treatment of acute diarrhoea should not be routinely offered - appropriate for self-care
• OTC treatments can help replace lost fluids or reduce bowel motions

General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list.

If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records.

Click here for the Shared Care Guideline Repository


If sufficient information has not been provided and if you do not feel happy to continue to prescribe, it is advisable to refer the patient back to the specialist clinic and complete and send as soon as possible an 'inappropriate prescribing request communication form' .
 

PARENTERAL FORMULATION IS FOR HOSPITAL PRESCRIBING ONLY

• According to the East London Health and Care Partnership HOSPITAL ONLY PRESCRIBING LIST this is UNSUITABLE for prescribing in Primary Care.
• HOSPITAL ONLY PRESCRIBING LIST

PARENTERAL FORMULATION IS FOR HOSPITAL PRESCRIBING ONLY